| Name | Title | Contact Details |
|---|
With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.
MicroMed Cardiovascular Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
UltraSPECT is a Merrick, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Regenesis Biomedical Inc is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.